KRAS and cancer: This highly significant finding establishes for the first time a direct effect of RAS on metabolism, represents the first demonstration of a biochemical difference between KRAS splice variants, and suggests a unique vulnerability for KRAS driven cancers that express oncogenic KRAS4A.